Normal Blood Pressure and Hypertension Treatment Goals
Normal blood pressure for adults is <120/80 mmHg, and for diagnosed hypertension, the treatment target should be <130/80 mmHg for most patients, with efforts to achieve systolic BP of 120-129 mmHg when well-tolerated.
Normal Blood Pressure Definition
Based on the most recent 2024 ESC guidelines 1, blood pressure categories are:
- Normal BP: <120/80 mmHg
- Elevated BP: 120-139/70-89 mmHg (new category introduced in 2024)
- Hypertension: ≥140/90 mmHg
The 2025 AHA/ACC guidelines 2 similarly define hypertension as BP ≥130/80 mmHg, representing a lower threshold than European guidelines.
Treatment Goals for Diagnosed Hypertension
Primary Target (All Patients)
The initial universal target is <140/90 mmHg for all adults with hypertension 1. Once this is achieved and treatment is well-tolerated, you should intensify therapy to reach <130/80 mmHg 3, 1.
Optimal Target (Most Adults)
For cardiovascular risk reduction, target systolic BP of 120-129 mmHg is recommended when treatment is well-tolerated 1, 2. This represents the most aggressive evidence-based target and is supported by trials like SPRINT showing reduced cardiovascular events and mortality 2.
The diastolic target should be <80 mmHg, with optimal range of 70-79 mmHg 3, 1.
Age-Specific Modifications
Older Adults (≥65 years)
- Target systolic BP: 130-139 mmHg 1
- The 2025 AHA/ACC recommends <130 mmHg for community-dwelling, ambulatory older adults if tolerated 2
- For those ≥85 years: consider more lenient targets (e.g., <140 mmHg) 1
Very Elderly (≥80 years)
European guidelines recommend <150/90 mmHg based on HYVET trial data 4, though newer 2024 ESC guidelines have moved toward lower targets of 130-139 mmHg 1.
Special Populations
High Cardiovascular Risk Patients
Target <130 mmHg systolic (strong recommendation) 5, 2. High risk is defined as 10-year CVD risk ≥7.5% using PREVENT equations 2.
Patients with Diabetes or Chronic Kidney Disease
- Target: <130/80 mmHg 3
- Previous recommendations for <130/80 mmHg in these populations have been validated 4
- ESC specifies CKD patients should target 130-140 mmHg systolic 3
Frail Patients or Limited Life Expectancy
More lenient targets of <140/90 mmHg may be considered 1. This applies to:
- Moderate-to-severe frailty at any age
- Limited predicted lifespan (<3 years)
- Symptomatic orthostatic hypotension
Key Differences Between Guidelines
There is notable divergence between American and European approaches:
- 2025 AHA/ACC 2: Defines hypertension at ≥130/80 mmHg, recommends pharmacotherapy earlier, and encourages SBP <120 mmHg
- 2024 ESC 1: Defines hypertension at ≥140/90 mmHg, uses "elevated BP" for 120-139/70-89 mmHg range, targets 120-129 mmHg but advises against specifically targeting <120 mmHg
- 2023 ESH: Recommends avoiding active targeting of SBP <120 mmHg 6
Critical Caveats
Confirm targets with out-of-office measurements: Home or ambulatory BP monitoring should verify that office targets translate to appropriate out-of-office control 1, 2
Monitor for adverse effects: Hypotension, syncope, falls, electrolyte abnormalities, and acute kidney injury are more common with intensive treatment but generally mild 2
Diastolic BP floor: When systolic target is achieved but diastolic remains 70-79 mmHg, continue treatment if tolerated; avoid pushing diastolic <70 mmHg 3, 1
Individualization required for: Orthostatic hypotension, age ≥85 years, significant frailty, high comorbidity burden 1, 2
Treatment Algorithm
- Initial goal: Achieve <140/90 mmHg within 3 months 3
- Secondary goal: If tolerated, intensify to <130/80 mmHg 3, 1
- Optimal goal: For most adults 18-65 years and high-risk patients, target 120-129 mmHg systolic if well-tolerated 1, 2
- Reassess monthly after medication changes until target achieved, then every 3-6 months 3, 5